Opioid peptides (acting through mu, delta, and kappa receptors) and serotonin modulate the non-adrenergic, non-cholinergic nerve pathways that control intestinal relaxation in the rat duodenum.
All 3 opioid receptor types activeMu, delta, and kappa opioid agonists all produced dose-dependent increases in gut relaxation, reversed by naloxone
What the researchers found
Opioid peptides acting through all three receptor types (mu, delta, kappa) enhance non-adrenergic non-cholinergic inhibitory responses in the duodenum, while serotonin reduces them.
Why it matters
Understanding how opioid peptides regulate gut motility helps explain both the constipating effects of opioid drugs and the potential role of endogenous opioid peptides in gut function disorders.
How the study worked
In vitro experiments using isolated rat duodenal segments with electrical field stimulation in the presence of atropine and guanethidine (to block standard pathways). Dose-response curves were generated for opioid agonists (DAGO, DPDPE, dynorphin) and serotonin.
What this study cannot tell us
In vitro study using isolated rat gut tissue. Results may not directly translate to intact gut physiology or human intestinal function.
How to read the evidence
Preliminary in vitro evidence from isolated rat tissue. Well-controlled pharmacological study but limited physiological relevance.
When this study was published
Published in 1993, this study contributed to the early understanding of opioid peptide roles in gut physiology.
The bigger picture
This research contributed to understanding the gut's complex nerve regulation system, relevant to conditions like irritable bowel syndrome where non-standard nerve pathways and serotonin both play key roles.
Questions still open
- Could selective opioid receptor agonists be used to treat gut motility disorders without the side effects of traditional opioids?
- How do endogenous opioid peptide levels in the gut change in conditions like IBS?
Common questions
What are non-adrenergic non-cholinergic nerves?
Why do opioids cause constipation?
Read the original research
Modulation of non-adrenergic non-cholinergic inhibitory transmission in rat duodenum: role of opiates and 5-hydroxytryptamine.
Archives italiennes de biologie, 131(2-3), 235-43
Citation
Postorino, A; Serio, R; Mulè, F; Adamo, E B; Di Giovanni, G; Marini, R. (1993). Modulation of non-adrenergic non-cholinergic inhibitory transmission in rat duodenum: role of opiates and 5-hydroxytryptamine.. Archives italiennes de biologie, 131(2-3), 235-43.